Advocacy Actions

2020-09-15 > Beijing

Comments to the National Medical Products Administration (NMPA) on Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications

On 15th September 2020, the Cosmetics Working Group submitted the comments to NMPA upon Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications regarding articles with different opinions from member companies.

Read more
2020-08-28 > Beijing, Shanghai, South China

Comments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)

The European Chamber submitted collated comments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)

Read more
2020-08-28 > Beijing

Submitted Comments to the National Medical Products Administration (NMPA) on the Product Safety Assessment Guidelines

On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Safety Assessment Guidelines regarding articles with different opinions from member companies.

Read more
2020-08-28 > Beijing

Submitted Comments to the National Medical Products Administration (NMPA) on Product Classification Scheme

On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Classification Scheme regarding articles with different opinions from member companies.

Read more
2020-08-19 > Beijing

Submitted Final Comments to the National Medical Products Administration (NMPA) on the Management Rules for Cosmetic Registration

On 19th August 2020, the Cosmetics Working Group submitted the final comments to NMPA Division 1 upon the Management Rules for Cosmetic Registration regarding articles with different opinions from member companies.

Read more
2020-08-19 > Beijing

Submitted Final Comments to the National Medical Products Administration (NMPA) on the Measures on Supervision and Administration of Cosmetic Manufacture and Operation

On 19th August 2020, the Cosmetics Working Group submitted the final comments to NMPA upon the Measures on Supervision and Administration of Cosmetic Manufacture and Operation regarding articles with different opinions from member companies.

Read more
2020-08-07 > Beijing

Meeting with EUD DG Grow first counsellor Frank Schmiedel

On 7th August, a meeting with the first counsellor of the Delegation of the European Union Frank Schmiedel.

Read more
2020-08-07 > Beijing

Submitted comments on the Draft Revision of the Product Quality Law to SAMR

Submitted comments on the Draft Revision of the Product Quality Law to SAMR

Read more
2020-07-10 > Beijing

Had a joint working group meeting and discussion on the Product Quality Law revision

Had a joint working group meeting and discussion on the Product Quality Law revision

Read more
2020-07-09 > Beijing

Follow up Comments to NMPA Division1's Meeting upon the Management Rules for Cosmetic Registration

On 9th July, the Cosmetics Working Group submitted follow up comments to NMPA upon the Management Rules for Cosmetic Registration regarding Articles with different opinions from member companies.

Read more